Skip to main content

and
  1. Article

    Open Access

    Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome

    Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) is an emerging tick-borne virus with high fatality and an expanding endemic. Currently, effective anti-SFTSV intervention remains unavailable. F...

    Hao Li, **a-Ming Jiang, Ning Cui, Chun Yuan in Signal Transduction and Targeted Therapy (2021)

  2. Article

    Open Access

    RING finger 138 deregulation distorts NF-кB signaling and facilities colitis switch to aggressive malignancy

    Prolonged activation of nuclear factor (NF)-кB signaling significantly contributes to the development of colorectal cancer (CRC). New therapeutic opportunities are emerging from targeting this distorted cell s...

    Yalan Lu, Rong Huang, Jianming Ying in Signal Transduction and Targeted Therapy (2022)

  3. Article

    Open Access

    Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1

    Indoleamine 2,3-dioxygenase 1 (IDO1), the enzyme that catabolizes tryptophan (Trp) metabolism to promote regulatory T cells (Tregs) and suppress CD8+ T cells, is regulated by several intrinsic signaling pathways....

    Fan Liang, Gui-Zhen Wang, Yan Wang in Signal Transduction and Targeted Therapy (2022)

  4. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)